Scientists Scientific Advisory Board Directors
The Foundation for OCD Research
 

We’re funding revolutionary breakthroughs in Neuroscience to treat OCD

 
 

We have a radical mission:

  • Deliver a functional “cure” for OCD in our lifetime

  • De-risk therapeutic discovery and development for BigPharma

  • Radically transform R&D, streamlining and accelerating scientific breakthroughs

 

We’re taking an Entrepreneurial Approach:

  • Prototyping mindset and strategic focus (on near-term therapies)

  • End-to-end process (from genetics to the lab to the clinic)

  • Integrated and multidisciplinary – 15 teams (vs. silo’d and scattered)

  • Financially efficient (synergies through streamlined processes)

 

We’re Delivering Early Insights + Breakthroughs:

  • 10 De novo genes identified

  • rTMS clinical trial almost completed

  • SEEG/DBS project in process

  • Scientific synergies (shared research, publishing, and tool innovations, etc.) 

  • Spillover benefits into other brain disorders, e.g. anxiety, depression

 
 

$100M MOONSHOT PROJECT:

$75M Raised  /  $25M to Go

 
 
 
 
“These high-confidence genes and molecular insights are a sea change in what we know about the genetics of OCD — and it’s a direct consequence of the FFOR investment.”
— Matthew State, M.d., Ph.D.

DR. MATTHEW STATE is a FFOR Principal Investigator and Chair of Psychiatry & Behavioral Sciences at UCSF

 
 

DR. RANDY BUCKNER is a FFOR Scientific Advisory Board member and Professor
of Psychology at Harvard University

“We’re bending the trajectory of care for patients with OCD, assembling the right people at the right time and on a scale that would not be possible without the strategy and funding of FFOR.”
— Randy Buckner, Ph.D.
 
 

For far too long research on OCD has been neglected, while adjacent topics in mental health and neuroscience have leapt forward, and primarily for one reason — funding.